Non vaxers
So all you you sheep are you convinced that us who refused the fake vaccine were right
This page is a permanent link to the reply below and its nested replies. See all post replies »
ElwoodBlues · M
@Amyrakunejo writes:
The mRNA vaccines were tested in large trials of 30,000 and 45,000 subjects for Moderna & Pfizer respectively. There were also animal trials.
"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine"
https://www.nejm.org/doi/full/10.1056/nejmoa2035389
Conclusions
The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease. Aside from transient local and systemic reactions, no safety concerns were identified. (Funded by the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases; COVE ClinicalTrials.gov number, NCT04470427.)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
https://www.nejm.org/doi/full/10.1056/nejmoa2034577
Conclusions
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.)
Moderna animal trials
https://www.nejm.org/doi/10.1056/NEJMoa2024671
Pfizer animal trials
https://www.nature.com/articles/s41586-021-03275-y
BTW, the first clinical trials of an mRNA vaccine in humans were in 2014 & 2015. Animal trials started in 2012.
Basically, the 'vaccines' everyone got were live trials.
FALSE.The mRNA vaccines were tested in large trials of 30,000 and 45,000 subjects for Moderna & Pfizer respectively. There were also animal trials.
"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine"
https://www.nejm.org/doi/full/10.1056/nejmoa2035389
Conclusions
The mRNA-1273 vaccine showed 94.1% efficacy at preventing Covid-19 illness, including severe disease. Aside from transient local and systemic reactions, no safety concerns were identified. (Funded by the Biomedical Advanced Research and Development Authority and the National Institute of Allergy and Infectious Diseases; COVE ClinicalTrials.gov number, NCT04470427.)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
https://www.nejm.org/doi/full/10.1056/nejmoa2034577
Conclusions
A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 months was similar to that of other viral vaccines. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.)
Moderna animal trials
https://www.nejm.org/doi/10.1056/NEJMoa2024671
Pfizer animal trials
https://www.nature.com/articles/s41586-021-03275-y
BTW, the first clinical trials of an mRNA vaccine in humans were in 2014 & 2015. Animal trials started in 2012.